Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines.

Lin, Dan-Yu; Zeng, Donglin; Gilbert, Peter B

Lin, Dan-Yu; Zeng, Donglin; Gilbert, Peter B.

Affiliation

Lin DY; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
Zeng D; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutch, Seattle, Washington, USA.

Clin Infect Dis ; 73(10): 1927-1939, 2021 11 16.

Article in En | MEDLINE | ID: mdl-33693529

Subject(s)

COVID-19; Vaccines; COVID-19 Vaccines; Humans; Pandemics; SARS-CoV-2

Key words

SARS-CoV-2; booster vaccination; crossover; durability of vaccine efficacy; phase 3 trials; waning efficacy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google